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How is the LPFC activity related to the ac-
tivity in MT+ in the task-irrelevant condi-
tion? The correlation coefficient between the
task-irrelevance–related activity (28) in MT+
and the LPFC was –0.90. This is in accord with
the view that when the LPFC is activated, it
provides direct or indirect inhibitory control on the
activity of MT+.
One might think that the low performance at
the 5% coherence ratio was obtained because,
despite the instructions to focus on RSVP task
performance, the participants may have tried to
find a coherent motion direction or to detect
whether coherent motion was presented. If these
motion tasks are difficult, they may leave fewer
resources available for the RSVP task. However,
this is not likely. If the participants engaged in
the search for motion direction, this task should
be hardest at 0% coherence and therefore, the
lowest RSVP performance should have occurred
at 0% and not at 5% coherence. Second, if the
participants engaged in motion detection, this
task should be hardest at 5% coherence because
indecision may be greatest near the coherent
motion threshold, and thus in accordance with
the observed RSVP performance result. How-
ever, the lowest blood oxygen level–dependent
(BOLD) activity was observed at 5% coherence
ratio in the LPFC and cannot be directly
explained by this possibility.
The results of the present study demon-
strate two important points. First, a weak task-
irrelevant stimulus feature that is below but near
the perceptual threshold more strongly activates
the visual area (MT+) that is highly related to the
stimulus feature and more greatly disrupts task
performance. There was a tendency for activity
in the posterior occipitotemporal sulcus (pOTS)
(29, 30) and the left angular gyrus (31), which
are sensitive to letters and words and may be
related to the RSVP task, to be lower at the 5%
coherence than at the other coherent motion
ratios. This contradicts the general view that ir-
relevant signals that are stronger in stimulus
properties have a greater influence on the brain
and performance and that the influence of a
subthreshold stimulus is smaller than that of a
suprathreshold stimulus.
Second, the results may reveal important
bidirectional interactions between a cognitive
controlling system and the visual system. The
LPFC, which has been suggested to provide
inhibitory control on task-irrelevant signals
(22–26), may have a higher detection threshold
for incoming signals than the visual cortex.
Task-irrelevant signals around the threshold
level may be sufficiently strong to be processed
in the visual system but not strong enough
for the LPFC to notice and, therefore, to pro-
vide effective inhibitory control on the signals
(Fig. 4A). In this case, such signals may remain
uninhibited, take more resources for a task-
irrelevant distractor, leave fewer resources for a
given task (32, 33), and disrupt task performance
more than suprathreshold signals. On the other
hand, suprathreshold coherent motion may be
noticed, may be given successful inhibitory con-
trol by the LPFC, and may leave more resources
for a task (Fig. 4B) (22–26). This mechanism
may underlie the present paradoxical finding
that subthreshold task-irrelevant stimuli activate
the visual area strongly and disrupt task perform-
ance more than some suprathreshold stimuli.
It could also be one of the reasons why sub-
threshold stimuli often lead to relatively robust
effects (2, 11, 14).
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Maternal Oxytocin Triggers a Transient
Inhibitory Switch in GABA Signaling in
the Fetal Brain During Delivery
Roman Tyzio,1 Rosa Cossart,1 Ilgam Khalilov,1 Marat Minlebaev,1 Christian A. Hübner,2
Alfonso Represa,1 Yehezkel Ben-Ari,1* Rustem Khazipov1
We report a signaling mechanism in rats between mother and fetus aimed at preparing fetal
neurons for delivery. In immature neurons, g-aminobutyric acid (GABA) is the primary excitatory
neurotransmitter. We found that, shortly before delivery, there is a transient reduction in the
intracellular chloride concentration and an excitatory-to-inhibitory switch of GABA actions. These
events were triggered by oxytocin, an essential maternal hormone for labor. In vivo administration
of an oxytocin receptor antagonist before delivery prevented the switch of GABA actions in fetal
neurons and aggravated the severity of anoxic episodes. Thus, maternal oxytocin inhibits fetal
neurons and increases their resistance to insults during delivery.
Delivery is a stressful event associatedwithhigh risks to the fetal brain (1); however,whether the fetal brain prepares for delivery remains largely unknown. We addressedthis issue by studying g-aminobutyric acid(GABA)–mediated (GABAergic) signaling in the
15 DECEMBER 2006 VOL 314 SCIENCE www.sciencemag.org1788
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rat hippocampus. GABA is the principal inhibitory
neurotransmitter in the adult brain. However,
during fetal and postnatal periods GABA has a
depolarizing action (2–4) and provides the major,
and often the only, excitatory synaptic input to
immature neurons (5). Excitatory action of GABA
is due to elevated intracellular chloride and de-
polarized value of the GABA type A (GABAA)
reversal potential (EGABA) (6–10). Excitatory
GABA is pivotal in control of neuronal firing,
generation of the primitive patterns of activity,
intracellular calcium signaling, and neuronal
development (2, 3). GABA signaling is therefore
expected to be an essential element in physiolog-
ical adaptation to stress during delivery.
To characterize the properties of GABA sig-
naling during the perinatal period, we used cell-
attached recordings from fetal and neonatal rat
hippocampal slices [from embryonic day (E) 18 to
postnatal day (P) 5; term is E21] (11). During fetal
(E18 and E19) and postnatal periods (P1 to P5),
activation of GABAA receptors increased the firing
of action potentials in the majority of CA3
pyramidal cells [Fig. 1A; also (6, 7, 12)]. However,
during a brief period extending from E20 to day of
birth (P0), the proportion of cells excited byGABA
sharply decreased. The loss of the excitatory effect
of GABA peaked at E21 [~1 to 2 hours before
delivery (Fig. 1A)].
The action of GABA depends on the direction
of the transmembrane current elicited by GABA,
its driving force (DFGABA) being the difference
between EGABA and resting membrane potential
(Em). Positive values of DFGABA determine
excitatory actions of GABA in immature neurons
(2, 3, 6, 7). To estimate DFGABA, we used cell-
attached recordings of single GABAA channels
(10) (Fig. 1, B to D), which affect neither EGABA
nor Em. With 1 mMGABA in the pipette solution,
GABAA channels were observed in ~90% of
patches (n = 553) but not in the presence of the
GABAA receptor antagonist picrotoxin [100 mM;
n = 25 (Fig. 1B)]. We found that DFGABA is
strongly depolarizing in fetal and postnatal periods
(Fig. 1D). However, DFGABA negatively shifted
during a brief near-term period (from E20 to P0),
switching to a hyperpolarizing value of –8.4 ±
2.5 mVat term [mean ± SEM, n = 34 (Fig. 1D)].
Thus, the disappearance of GABA-mediated ex-
citation at term (Fig. 1A) coincides with a switch
in polarity of GABA signals.
The perinatal changes in DFGABA could be due
to a negative shift ofEGABA or to a depolarizing shift
of Em. By using cell-attached recordings of single
N-methyl-D-aspartate (NMDA) channels as volt-
age sensors (12, 13), we found that during early
fetal and postnatal periods Em is –78.7 ± 1.9 mV
(n= 42; pooled data for E18 and E19 and P1 to P5)
[also (13, 14)], but near term there is a small hyper-
polarizing shift to –85.4 ± 1.5 mV [n = 14 at birth
(Fig. 1E)]. Knowing DFGABA and Em, we cal-
culated EGABA (EGABA = DFGABA + Em) and
found that EGABA switches from –40mVat E18 to
–92 mV at E21 and then returns to depolarizing
values shortly after birth (Fig. 1F). This corre-
sponds to a decrease in [Cl–]i (intracellular chloride
concentration) from 18 mM to 4 mM (Fig. 1F).
Because GABA-induced depolarization
raises [Ca2+]i (12, 15–18), we used a multibeam
two-photonmicroscope tomonitor [Ca2+]i changes
in hundreds of CA3 neurons in slices loaded with
the calcium indicator fura 2-AM (Fig. 2). The
GABAA receptor agonist isoguvacine (10 mM)
elicited a robust increase of [Ca2+]i in the ma-
jority of neurons at E18 and at P2 to P4 [average of
56 ± 3%, n values of 7 movies and 931 cells (Fig.
2, B to D)]. In contrast, at E21 to P0, [Ca2+]i
increased in only 31 ± 6% (n values of 10 movies
and 1546 cells, P < 0.01) cells. Isoguvacine also
decreased the frequency of spontaneous calcium
1Institut de Neurobiologie de la Méditerranée, INSERM
U29, Université de la Méditerranée, Campus Scientifique
de Luminy, Boite Postale 13, 13273 Marseille Cedex 09,
France. 2Institut für Humangenetik, Universitätsklinikum
Hamburg-Eppendorf, 20251 Hamburg, Germany.
*To whom correspondence should be addressed. E-mail:
ben-ari@inmed.univ-mrs.fr
Fig. 1. Transient perinatal loss of the GABAA-
mediated excitation. (A) Responses of CA3 py-
ramidal cells recorded in cell-attached mode to
the GABAA agonist isoguvacine. Below, summa-
ry plot of the proportion of cells excited by
isoguvacine during the perinatal period. There
is a transient loss of the excitatory effect of
isoguvacine near term. Red corresponds to the
fetuses whose mothers received SSR126768A.
[E21 corresponds to the early phase of delivery
(1 to 2 hours before birth); P0 is the day of
birth; pooled data from 146 neurons.] (B) Cell-
attached recordings of single GABAA channels
with 1 mM of GABA in patch pipette (top trace);
the channels were not observed in the presence
of the GABAA antagonist picrotoxin (100 mM;
bottom trace). (C) I-V relationships of the
currents through GABAA channels in two cells
at E21 and E18; their reversal potential
corresponds to DFGABA. (D) Summary plot of
the age dependence of DFGABA inferred from
single GABAA channels recordings [mean ±
SEM; 209 CA3 pyramidal cells (○) and 17
neocortical pyramidal cells (□); 6 to 24 patches
for each point]. Red indicates pretreatment with
SSR126768A (n values are 25 hippocampal and
9 neocortical patches). (E) Age dependence of
the resting membrane potential (Em) of CA3
pyramidal cells inferred from the reversal of
single NMDA channels recorded in cell-attached
mode (n = 84 cells; 4 to 12 patches for each
point). (F) Age dependence of the GABAA
reversal potential (EGABA = Em + DFGABA). There
is a transient hyperpolarizing shift of EGABA
near birth.
www.sciencemag.org SCIENCE VOL 314 15 DECEMBER 2006 1789
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events in many neurons near term [9 ± 2% (Fig.
2)]. Thus, during delivery, the ability of GABA to
increase [Ca2+]i is significantly reduced.
What underlies the near-term switch in GABA
actions? Because this phenomenon is not observed
in fetal neurons grown in culture (8, 9), we
hypothesized that it is related to parturition and in
particular to maternal hormones released during
delivery. Parturition is initiated by amassive release
of oxytocin (19). In addition to its pivotal role in
parturition, there are also indications that oxytocin
exerts multiple effects in the adult central nervous
system (19–25). Maternal oxytocin easily crosses
the placenta to reach the fetus (26), suggesting that
oxytocin may be responsible for the hyperpolariz-
ing switch in action of GABA in fetal neurons
during delivery. With selective antibodies, we
found a high density of oxytocin receptor immu-
noreactivity in the hippocampus and neocortex
during the perinatal period (Fig. 3A and figs. S1
and S2). During cell-attached recordings from
slices at E18 and P2, applications of oxytocin
(1mM) induced anegative shift inDFGABA (Fig. 3,C
andD) and suppressedGABA-mediated excitation
(Fig. 3B). The effects of oxytocin were completely
prevented by bath application of the selective oxy-
tocin receptor antagonist atosiban (AT, 1 to 5 mM)
(Fig. 3D). At term, application of oxytocin did not
cause a significant effect on the hyperpolarizing
DFGABA (Fig. 3D), suggesting that the effects of
exogenous oxytocin are occluded by the endog-
enous hormone. In keeping with this hypothesis,
we found that atosiban switched DFGABA from
hyperpolarizing to depolarizing at term but not in
fetal and postnatal neurons (Fig. 3D). Moreover,
intracardial perfusion of E21 fetuses with artifi-
cial cerebrospinal fluid (ACSF, to wash out
endogenous hormone) produced a similar shift
ofDFGABA from hyperpolarizing to depolarizing
(fig. S3). Addition of 1 mMoxytocin at the end of
the perfusion restored hyperpolarizing values of
DFGABA (fig. S3). Therefore, endogenous oxy-
tocin is present in slices at term and provides
tonic activation of oxytocin receptors, leading to
the shift of DFGABA. We also found that the neg-
ative shift inDFGABA from 38.4 ± 6.2 mV (n = 8)
to –7.2 ± 2.2 mV (n = 18) occurred in E18 fetuses
obtained from mothers treated with oxytocin
(50 mg/kg) during 2 hours before cesarean delivery.
To directly measure the effects of oxytocin on
[Cl–]i, we used two-photon chloride imaging in
slices loaded with a chloride-sensitive dye, MQAE
(Fig. 3, E and F) (27). In E18 and P4 slices, oxy-
tocin (1 mM) produced a significant increase in the
baseline fluorescence signal in half of the imaged
cells, indicating a strong reduction of [Cl–]i
[average of 43 ± 4%, n values of 10 movies and
1792 cells (Fig. 3F)], and the effect was prevented
by atosiban (5 mM; reduction of [Cl–]i in 5 ± 3%
cells, n values of 2 movies and 435 cells). Fur-
thermore, incubation of P4 slices with oxytocin
reversed the effect of isoguvacine on spontaneous
calcium events [59 ± 17% imaged cells not ac-
tivated by isoguvacine, n values of 3 movies and
228 cells (fig. S4)]. Thus, the effects of oxytocin
fully matched the changes in GABA signaling
occurring at term. This result indicates that oxy-
tocin is sufficient to trigger changes of [Cl–]i.
To determine whether endogenous oxytocin is
necessary for the near-term switch in the action of
GABA, we treated pregnant rats orally with the
selectiveoxytocin receptor antagonist SSR126768A
(28) (1 mg/kg, starting from E20) andmeasured the
consequences at term. Cell-attached recordings
revealed major differences between treated and
age-matched control pups, including strongly
depolarizing values ofDFGABA (Fig. 1D, red circle)
and a high proportion of cells excited by GABA
(Fig. 1A, red circle). Similar effects were also
observed in neocortical neurons, in whichDFGABA
was –9.4 ± 3.4 mV in control rat pups (n = 8) and
28.3 ± 3.7mV (n = 9) in pups of mothers pretreated
with SSR126768A (Fig. 1D). Thus, maternal
oxytocin is necessary and sufficient to trigger the
near-term switch in GABA action in the hippo-
campus and neocortex.
What are the mechanisms underlying the
oxytocin-mediated reduction of [Cl–]i at term?
Because the NKCC1 chloride inward cotransporter
is responsible for elevated [Cl–]i in immature
neurons (4, 7, 29, 30), we tested the effects of the
selectiveNKCC1 antagonist bumetanide.We found
that bumetanide (10 mM) produces a robust
negative shift of DFGABA and occludes the effects
of oxytocin (fig. S5). The short latency of oxytocin
actions (Fig. 3F) and the observation that blockade
of oxytocin receptors does not alter chloride
transporters gene expression (fig. S6) suggest that
the hormone down-regulates NKCC1 activity.
Hypoxic-ischemic brain damage is a principal
cause of newborn death and neurological impair-
ment (1). We hypothesized that the excitatory-to-
Fig. 2. Perinatal effects of GABAA receptors
activation on [Ca2+]i in CA3 neurons. (A) Two-
photon [Ca2+]i fluorescence image of the CA3
region from a P0 hippocampal slice loaded with
fura 2-AM; scale bar indicates 100 mm. (Right)
Automatically detected contours of the cells. (B)
Three types of [Ca2+]i responses (DF/F) to bath ap-
plication of the GABAA agonist isoguvacine (10 mM,
1 min): excited (red), inhibited (blue), or not af-
fected (black) by isoguvacine (Isog). (C) Contour
maps representing the distribution of different
cellular responses to isoguvacine at E18, P0, and
P5: excited (red), inhibited (blue), and not
affected (open contours). Bottom histograms show
the percentage of cells that are detected as being
active on each movie frame corresponding to the
above contour plots (140 ms per frame). Iso-
guvacine application (10 mM) produces a signif-
icant increase in the fraction of active neurons at
E18 and P5, whereas it slightly decreased the
activity at birth. (D) Histograms of the averaged
fraction of imaged neurons excited (top) or
inhibited or nonaffected (bottom) by isoguvacine
at different ages (for P0, n values of 10 movies
and 1546 cells; for E18, n values of 2 movies and
375 cells; and for P5, n values of 3 movies and
328 cells; *P < 0.01). Error bars indicate SEM.
15 DECEMBER 2006 VOL 314 SCIENCE www.sciencemag.org1790
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inhibitory switch in GABA signaling reduces
neuronal activity andmetabolic demand, thus help-
ing to protect fetal neurons from hypoxic insults
(31). Episodes of anoxia and aglycemia were
induced by superfusion with a solution in which
oxygen was substituted for nitrogen and glucose
was substituted for sucrose. The onset of anoxic
depolarization (AD) that is an electrophysiological
marker of neuronal death (31, 32) wasmeasured by
using extracellular field potential recordings in the
intact hippocampi of E21 rats in vitro after various
treatments in vivo to the mother and/or to the
fetuses intracardially before the in vitro experiment
(Fig 4). In control fetuses, AD occurred after 55.6 ±
1.4 min (n = 30) of perfusion with the anoxic-
aglycemic solution (Fig. 4). In the hippocampi
prepared from the fetuses intracardially perfusedwith
atosiban (5 mM; n = 15) or from the fetuses whose
mothers received SSR126768A (1 mg/kg; n = 19),
AD onset was significantly accelerated to 44.1 ±
1.1 min (n = 34; P < 0.01). Bumetanide (10 mM)
applied in the presence of the oxytocin receptor
antagonists delayed AD to the control values (53.4 ±
1.7 min; n = 18; P < 0.01). Bumetanide (10 mM)
Fig. 3. Oxytocin causes a switch in GABAA
signaling from depolarizing to hyperpolarizing.
(A) Oxytocin-receptor immunostaining of a P0
rat hippocampus; (inset) CA3 pyramidal cells
layer. Bars, 200 mm and (inset) 20 mm. (B)
Histograms of the proportion of cells excited by
brief application of isoguvacine (Isog) in control
and in the presence of oxytocin (1 mM) at E18
and P2 (n = 57 cells). (C) I-V relationships of
the currents through single GABAA channels
recorded from two CA3 pyramidal cells at E18
in control and after addition of oxytocin (1 mM).
(D) Histograms of DFGABA measured at E18,
E21, and P2 in control conditions and in the
presence of oxytocin (1 mM), antagonist of
oxytocin receptors atosiban (1 to 5 mM), and
oxytocin plus atosiban (n = 187 cells). (E) Two-
photon imaging of [Cl–]i in P4 hippocampal
slice loaded with Cl– indicator MQAE. Scale bar,
100 mm. (Right) [Cl–]i fluorescence change
produced by oxytocin application. The intensity
of the fluorescence signal increases, and [Cl–]i
decreases, in the illustrated region. (F) Auto-
matically detected contours of the cells imaged
in (E), indicating the distribution of cells in
which oxytocin application produced a signifi-
cant decrease in [Cl–]i (blue filled contours). On
the right, chloride fluorescence changes (DF/F)
in four representative neurons. Time resolution
is 100 ms per frame.
Fig. 4. Blockade of oxytocin receptors decreases fetal
brain resistance to anoxia-aglycemia at birth. (A)
Representative traces to illustrate the effects of
anoxic-aglycemic solution on extracellular field
potential recordings from E21 intact hippocampi.
Arrows indicate terminal AD that marks neuronal
death. AD occurs earlier in the presence of
SSR126768A (middle trace). Addition of bumetanide
(10 mM) occludes the effects of the antagonist and
restores the initial delay (bottom trace). (B) Summary
plot of the onset of AD in control, in the presence of the
oxytocin receptors antagonists atosiban (AT, 5 mM, fetal
intracardial perfusion and SSR126768A (1 mg/kg to
the mother), and after further addition of bumetanide
(10 mM). Each circle corresponds to one hippocampus
(n = 82 intact hippocampi at E21). Error bars indicate SEM.
www.sciencemag.org SCIENCE VOL 314 15 DECEMBER 2006 1791
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occluded the effects of the oxytocin receptor
antagonists and restored the control delays (53.4 ±
1.7 min, n = 18; P < 0.01). These data indicate that
maternal oxytocin exerts a neuroprotective action on
fetal neurons during parturition and that this action is
likely due to a reduction of [Cl–]i.
Our results suggest that oxytocin, in addition to
itswell-established role in labor and lactation and its
multiple effects in the adult central nervous system
(19–25), also exerts a powerful action on fetal
neurons. This mechanism adds a previously
unknown facet to the plasticity of GABA signaling
via modulation of [Cl–]i (4, 33). The dual action
produced by a single messenger in the mother and
fetus enables a perfect timing for adaptation of fetal
neurons to delivery.
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ATP Release Guides Neutrophil
Chemotaxis via P2Y2 and
A3 Receptors
Yu Chen,1* Ross Corriden,1,2* Yoshiaki Inoue,1 Linda Yip,1 Naoyuki Hashiguchi,1
Annelies Zinkernagel,4 Victor Nizet,4 Paul A. Insel,2,3 Wolfgang G. Junger1†
Cells must amplify external signals to orient and migrate in chemotactic gradient fields. We find
that human neutrophils release adenosine triphosphate (ATP) from the leading edge of the cell
surface to amplify chemotactic signals and direct cell orientation by feedback through P2Y2
nucleotide receptors. Neutrophils rapidly hydrolyze released ATP to adenosine that then acts via
A3-type adenosine receptors, which are recruited to the leading edge, to promote cell migration.
Thus, ATP release and autocrine feedback through P2Y2 and A3 receptors provide signal
amplification, controlling gradient sensing and migration of neutrophils.
Neutrophils are primary phagocytic cellswith important roles in host defense andtissue repair. However, activated neutro-
phils damage host tissues and contribute to chronic
inflammatory diseases, including rheumatoid arthri-
tis, inflammatory bowel disease, and asthma (1). A
key feature of neutrophils is their ability to detect
and migrate to compromised tissues by following a
concentration gradient of chemotactic substances
released from microbial pathogens or injured cells.
Neutrophils can respond to chemoattractant
gradients that differ in concentration by as little as
1% across the length of the cell body (2). Chemo-
taxis must involve signal amplification because a
strongly polarized distribution of intracellular signal-
transduction components is observed even in
shallow gradients. The mechanisms of signal am-
plification are unclear (3, 4). We identified the po-
larized release of adenosine triphosphate (ATP), the
activation of P2Y2 receptors, and the translocation
and activation of A3 adenosine receptors as key
mechanisms of signal amplification that control cell
orientation and direct the migration of neutrophils.
Membrane deformation caused by mechanical
or osmotic stress induces the release of cellular
ATP from mammalian cells; however, detailed
information on the underlying mechanisms is
lacking (5, 6). Because cell migration also involves
membrane deformation, we tested whether the
stimulation of human neutrophils with the chemo-
attractant N-formyl-Met-Leu-Phe (FMLP) causes
ATP release. Treatment of cells (107 cells in 250 ml
of solution) with 100 nM FMLP rapidly tripled
extracellular ATP concentrations in bulkmedia (Fig.
1, A and B) by inducing the release of ~0.5% of
their ATP pool. Concentrations of extracellular ATP
and its hydrolytic products adenosine monophos-
phate (AMP) and adenosine peaked 5 min after
FMLP stimulation; but while the concentration of
ATP returned to basal levels after 15 min, AMP
and adenosine concentrations remained >5–fold
above baseline (Fig. 1B), which is consistent with
the presence of ecto–adenosine triphosphatases
(ecto-ATPases) (7, 8). Neutrophils completely
hydrolyzed exogenous ATP (5 mM) within 2 min
after ATP addition, which suggests that they have
potent ecto-ATPase activity (Fig. 1C).
Because membrane deformation occurs pre-
dominantly at the leading edge closest to the chemo-
attractant source, we hypothesized this region to be
the principal site of ATP release. Fluorescent
microscopy that was used to visualize ATP release
[based on conversion of nicotinamide adenine
dinucleotide phosphate (NADP+) to its reduced
form NADPH] revealed that neutrophils discharge
ATP within seconds after FMLP stimulation (Fig.
1D and movies S1 to S3), with ATP release highest
near the cell membrane with the greatest degree of
protrusion (Fig. 1D, inset).
Extracellular ATP and adenosine modulate
neutrophil functions, including chemotaxis (8, 9).
We tested the effect of apyrase, which hydrolyzes
ATP, on chemotaxis in a trans-well system com-
posed of upper wells with neutrophils and lower
wells with 1 nM FMLP separated by a filter with
3-mm pores. Addition of apyrase to the upper wells
reduced chemotaxis by nearly 100% (Fig. 2A).
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